Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CREBBP | Q92793 | 2/20 | 0.51 |
| ▸ | VIM | P08670 | 1/20 | 0.49 |
| ▸ | MC4R | P32245 | 2/20 | 0.40 |
| ▸ | MC3R | P41968 | 2/20 | 0.40 |
| ▸ | MC1R | Q01726 | 1/20 | 0.40 |
| ▸ | MC5R | P33032 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ACE | P12821 | 1/20 | 0.34 |
| ▸ | BMP1 | P13497 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12754797 | 0.95 | CREBBP (0.50) | CREBBPVIMMC4RMC3RMC1R | |
| SCHEMBL17424484 | 0.94 | CREBBP (0.49) | CREBBPVIMMC4RMC3RMC1R | |
| SCHEMBL21565404 | 0.88 | CREBBP (0.50) | CREBBPVIMMC4RMC3RMC1R | |
| SCHEMBL17366443 | 0.86 | CREBBP (0.43) | CREBBPVIMMC4RMC3RMC5R | |
| SCHEMBL17366444 | 0.85 | CREBBP (0.43) | CREBBPVIMMC4RMC3RMC5R | |
| SCHEMBL17424488 | 0.83 | CREBBP (0.47) | CREBBPVIMMC4RMC3RMC1R | |
| SCHEMBL21376771 | 0.80 | MC4R (0.54) | CREBBPMC4RMC3RMC1RMC5R | |
| SCHEMBL21376767 | 0.80 | MC4R (0.54) | CREBBPMC4RMC3RMC1RMC5R | |
| SCHEMBL21376908 | 0.80 | MC4R (0.54) | CREBBPMC4RMC3RMC1RMC5R | |
| SCHEMBL21376481 | 0.80 | MC4R (0.54) | CREBBPMC4RMC3RMC1RMC5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090246124-A1 | HIGH AFFINITY VEGF-RECEPTOR ANTAGONISTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090246124-A1 | HIGH AFFINITY VEGF-RECEPTOR ANTAGONISTS | KDR, FLT4, FLT1 | CREBBP 4234/4885VIM 1222/4885MC4R 526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.